Suppr超能文献

噻唑并[5,4-f]喹唑啉-9(8H)-酮作为丝氨酸/苏氨酸激酶多靶点导向配体的合成

Synthesis of Thiazolo[5,4-f]quinazolin-9(8H)-ones as Multi-Target Directed Ligands of Ser/Thr Kinases.

作者信息

Hédou Damien, Godeau Julien, Loaëc Nadège, Meijer Laurent, Fruit Corinne, Besson Thierry

机构信息

Normandie Univ; Uni Rouen; INSA; CNRS, COBRA, UMR 6014, 76000 Rouen, France.

Protein Phosphorylation & Human Disease group, Station Biologique, 29680 Roscoff, France.

出版信息

Molecules. 2016 Apr 30;21(5):578. doi: 10.3390/molecules21050578.

Abstract

A library of thirty novel thiazolo[5,4-f]quinazolin-9(8H)-one derivatives belonging to four series designated as 12, 13, 14 and 15 was efficiently prepared, helped by microwave-assisted technology when required. The efficient multistep synthesis of methyl 6-amino-2-cyano- benzo[d]thiazole-7-carboxylate (1) has been reinvestigated and performed on a multigram scale. The inhibitory potency of the final products against five kinases involved in Alzheimer's disease was evaluated. This study demonstrates that some molecules of the 12 and 13 series described in this paper are particularly promising for the development of new multi-target inhibitors of kinases.

摘要

借助微波辅助技术(必要时),高效合成了一个包含30种新型噻唑并[5,4-f]喹唑啉-9(8H)-酮衍生物的文库,这些衍生物分属12、13、14和15四个系列。对6-氨基-2-氰基苯并[d]噻唑-7-羧酸甲酯(1)的高效多步合成进行了重新研究,并在数克规模上进行了制备。评估了最终产物对参与阿尔茨海默病的五种激酶的抑制效力。这项研究表明,本文所述的12和13系列中的一些分子在开发新型多靶点激酶抑制剂方面特别有前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f6a/6273584/41491183208a/molecules-21-00578-g001.jpg

相似文献

4
Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I.
Molecules. 2014 Sep 29;19(10):15546-71. doi: 10.3390/molecules191015546.
6
Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.
Molecules. 2014 Sep 26;19(10):15411-39. doi: 10.3390/molecules191015411.
9
Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
Curr Drug Targets. 2014 May;15(5):539-50. doi: 10.2174/1389450115666140226112321.

本文引用的文献

1
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Eur J Med Chem. 2016 Jan 1;107:63-81. doi: 10.1016/j.ejmech.2015.10.018. Epub 2015 Oct 21.
2
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs.
Drug Discov Today. 2016 Jan;21(1):5-10. doi: 10.1016/j.drudis.2015.07.008. Epub 2015 Jul 23.
3
FDA-approved small-molecule kinase inhibitors.
Trends Pharmacol Sci. 2015 Jul;36(7):422-39. doi: 10.1016/j.tips.2015.04.005. Epub 2015 May 12.
4
DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications.
Pharmacol Ther. 2015 Jul;151:87-98. doi: 10.1016/j.pharmthera.2015.03.004. Epub 2015 Mar 17.
6
Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I.
Molecules. 2014 Sep 29;19(10):15546-71. doi: 10.3390/molecules191015546.
7
Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.
Molecules. 2014 Sep 26;19(10):15411-39. doi: 10.3390/molecules191015411.
8
Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4.
ACS Med Chem Lett. 2014 Jul 14;5(9):963-7. doi: 10.1021/ml500059y. eCollection 2014 Sep 11.
9
10
Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
Curr Drug Targets. 2014 May;15(5):539-50. doi: 10.2174/1389450115666140226112321.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验